Breast Cancer Patients: A Breast Cancer Rehabilitation and Exercise Laboratory

Nevada Cancer Institute100 enrolled

Overview

The proposed study compares the outcomes of a physical activity intervention begun at diagnosis, continuing through active cancer treatment and into six months of survivorship compared to the outcomes of a control group receiving limited information on activity.

Patients (with stage 0 to stage III breast cancer)receiving chemotherapy, radiation or both chemotherapy and radiation will be included in the study.Randomization will be stratified by disease stage at diagnosis, treatment modalities planned, and hormonal status. Each patient will have a weekly goal of 2000 calories burned and 18 MET-hours of exercise which can be achieved in 4 to 7 hours of physical activity per week. Resistance training, using weight machines and aerobic training using treadmills, elliptical trainers and stationary bicycles, will be utilized in the intervention group. The control group will receive basic information on physical activity but not be instructed. Any physical activity in this group will be self-reported. Change in C-reactive protein will be the primary endpoint. Changes in other laboratory values, DEXA measurements, and quality of life measurements will be secondary endpoints.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Enrollment

100

Conditions

Early Stage Breast Cancer (Stage 0-III)

Interventions

Exercise RegimenOTHER

Exercise instruction

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Consent to participate in study 2. Women aged 18 and older 3. Stage 0 to III breast cancer prior to any treatment and at time of diagnosis 4. Requires treatment that includes chemotherapy, radiation therapy or both chemotherapy and radiation therapy 5. Adequate fitness to participate in a physical activity as assessed by the investigator 6. Willing and able to participate in a prescribed exercise program Exclusion Criteria: 1. Metastatic breast cancer (Stage IV) 2. Initiation of treatment regimen prior to enrollment 3. Treatment for breast cancer not requiring chemotherapy or radiation therapy 4. Patients who are pregnant (negative urine pregnancy test required at baseline to determine eligibility in women of child bearing potential). 5. Currently lactating 6. Do not read, understand, or speak English Eligible participants will not be included if they have: 1. known cardiac disease, 2. uncontrolled hypertension, 3. uncontrolled thyroid disease, 4. diabetes mellitus, 5. mental illness, 6. infection, 7. immune or endocrine abnormality, 8. body weight reduction I10% in past 6 months, and 9. positive exercise stress test. 10. Major surgery within last 6 months that requires exercise restriction

Locations (1)

Nevada Cancer Institute

Las Vegas, Nevada, United States

RECRUITING

Outcomes

Primary Outcomes

Changes in CRP

The primary endpoint for this study change in C-reactive protein.

Secondary Outcomes

Change in laboratory values

Compare changes in: * Glucose * Insulin * Estradiol * Testosterone

Change in body composition

Body composition parameters and bone density will be assessed using Dual Energy X-ray Absorptiometry (DEXA) and compared between the two groups.

Quality of Life

Quality of Life will be measured and compared between the groups

Overall Survival

Comparing overall survival and progression free survival between groups.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.